This study is looking for 100 people with heart failure to understand how different molecular profiles (multi-omics studies) relate to heart failure outcomes. It also aims to see if using telemonitoring devices (heart rate and blood pressure monitor, scale, and activity tracker) can help doctors optimize your treatment. You can join if you have a heart failure diagnosis, objective evidence of a heart abnormality (like an abnormal ECHO or high B-type natriuretic peptide levels over 100 pg/ml), and are between 21 and older. The main goal is to track adverse outcomes related to heart failure over five years. The current status of the study is unclear.

Study design

This is an interventional study planning to enroll 100 participants. It involves a randomized telemonitoring intervention.

What's involved

You would need to be able to use a smartphone to participate. The study will involve longitudinal profiling based on clinical data and multi-omics profiling.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for five years from enrollment to measure adverse outcomes.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.